The Global Anesthesia & Respiratory Devices Market Size accounted for USD 28.3 Billion in 2021 and is estimated to garner a market size of USD 49.9 Billion by 2030 rising at a CAGR of 6.5% from 2022 to 2030. The increasing prevalence of respiratory devices is one of the primary factors boosting the global anesthesia & respiratory devices market size. In addition, technological advancements in anesthesia monitoring are the popular anesthesia & respiratory devices market trend that is fueling the industry growth.
Anesthesia & Respiratory Devices PRP Market Report Key Highlights
Anesthesia and respiratory devices are equipped with ventilators that provide patients of respiratory failure with life-sustaining mechanical ventilation. Instruments and techniques for administering or delivering anesthesia to patients are known as anesthesia equipment and accessories. Respiratory treatment devices are also commonly used to diagnose and treat respiratory problems such as COPD, asthma, tuberculosis, and pneumonia.
Global Anesthesia & Respiratory Devices (PRP) Market Dynamics
Anesthesia & Respiratory Devices Market Report Coverage
|Market||Anesthesia & Respiratory Devices Market|
|Anesthesia & Respiratory Devices Market Size 2021||USD 28.3 Billion|
|Anesthesia & Respiratory Devices Market Forecast 2030||USD 49.9 Billion|
|Anesthesia & Respiratory Devices Market CAGR During 2022 - 2030||6.5%|
|Anesthesia & Respiratory Devices Market Analysis Period||2018 - 2030|
|Anesthesia & Respiratory Devices Market Base Year||2021|
|Anesthesia & Respiratory Devices Market Forecast Data||2022 - 2030|
|Segments Covered||By Product, By End-User, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||CAIRE Inc., B. Braun Medical Inc., Becton, Dickinson and Company, Medtronic plc, Drägerwerk AG, Getinge AB., GE Healthcare, Koninklijke Philips N.V., and Teleflex Incorporated.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
Impact of COVID-19 on anesthesia & respiratory care devices market
During the start COVID-19 pandemic, the hospitals had challenges in supplying emergency ventilation to individual patients due to unprecedented demand for hospital and ICU services. The US Department of Health and Human Services (HHS) and the Federal Emergency Management Agency (FEMA) collaborated with multiple organizations to sustain the balance between demand and supply of anesthesia and respiratory equipment, involving healthcare systems, research institutions, professional medical societies, and the National Academies of Science, Engineering, and Medicine. In addition, in response to inadequate supply and availability of anesthesia & respiratory devices, the FDA-cleared ventilators for use in healthcare settings to treat patients during the COVID-19 pandemic. To overcome such a challenging situation, the Food and Drug Administration (FDA) released an umbrella Emergency Use Authorization (EUA). Apart from that, the FDA collaborated closely with the Strategic National Stockpile (SNS) to develop strategies for the use of respirators and respiratory accessories in the SNS. High-flow nasal cannulae (HFNC) is a type of oxygen therapy that is less invasive than mechanical ventilation and has proven clinical effectiveness in the treatment of serious and critical COVID-19 patients, according to reports released by the US Department of Health and Human Services. The Office of the Assistant Secretary for Preparedness and Response (ASPR) is currently providing 30,000 HFNC kits for the Strategic National Stockpile (SNS) to allow GM/Ventec V+Pro ventilators to provide this type of therapy. This is the only probable respiratory model in the SNS. As part of the acquisition of the COVID-19 ventilator, the SNS presently holds 30,000 Ventec V+Pro ventilators that will be paired 1:1 with these new HFNC kits.
Anesthesia & Respiratory Devices Market Dynamics
Rising Prevalence of Respiratory Diseases Is Projected To Drive the Global Anesthesia & Respiratory Devices Market Globally
According to the World Health Organization (WHO), respiratory diseases are the leading cause of death and disability worldwide. About 65 million people suffer from the chronic obstructive pulmonary disorder (COPD) and 3 million die every year, making it the world's third leading cause of death. In addition, according to the Australian Disease Expenditure Study in 2015-2016, an estimated 3.5% of the total expenditure on disease in the Australian health system accounting for US$ 4 billion has been attributed to respiratory conditions. In addition, respiratory disease accounted for 7.5% of all deaths in the European Union (EU) in 2016.
High Government Involvement and Fast Product Approvals Propels the Growth of Respiratory & Anesthesia Devices Market Globally
According to reports published by The Therapeutic Goods Administration (TGA), the exemption has been announced, which began in April 2020 and remained in force until January 2021. The exemption encouraged ventilators manufactured in Australia to comply with minimum technical requirements to be supplied in Australia that meet the criteria of minimum technical requirements. In addition, ventilators to be supplied to hospitals have been exempted from TGA approval. This exemption was made to support the Australian Government's rapid response to the emergency COVID-19 by facilitating access to medical devices for the treatment of patients requiring invasive ventilation. In addition, the U.S. Department of Health & Human Services reports that, to shorten the time allowed for product licensing and reduce the spread of COVID-19, federal agencies aimed at identifying products and technologies that have progressed beyond non-clinical studies. Moreover, the formation of domestic large-scale manufacturing capacities combined with commercial Good Manufacturing Practices (cGMP) and the use of a platform to manufacture a product is already approved by the FDA.
Anesthesia & Respiratory Devices Market Segmentation
The worldwide anesthesia & respiratory devices market is split based on product, end-user, and geography.
Anesthesia & Respiratory Devices Market By Product
According to our anesthesia and respiratory devices industry analysis, respiratory devices are anticipated to witness fastest growth in the forecast period. Rising prevalence of respiratory devices, rising number of surgical procedures, and surging healthcare expenditure are the prominent factors that contribute for the growth of anesthesia & respiratory devices market globally.
Anesthesia & Respiratory Devices Market By End-User
As per our anesthesia and respiratory devices market forecast, the hospital end-user generated significant market share in 2021. In addition, the sub-segment is expected to continue its dominance throughout the forecasted years from 2022 to 2030. However, homecare settings sub-segment is currently booming across the world. In addition to that, growing consumer awareness about health and increasing disposable income the homecare settings is likely to attain a substantial growth rate in the coming years.
Anesthesia & Respiratory Devices Market Regional Outlook
The Middle East & Africa (MEA)
According to the U.S. Census Bureau, over 54 million adults aged 65 years and beyond were reported in the U.S. in 2021
North America is expected to have a dominant share in the forecast period. Rising adoption of technologically advanced devices in this region, an increase in investment by pharmaceutical companies, and an increase in healthcare expenditure are promising factors responsible for the growth of the global market for anesthesia and respiratory devices.
On the other hand, Asia-Pacific is expected to witness lucrative growth in recording all-time high CAGR in the coming years. Among the Asia-Pacific regional market, Japan seems to have the largest market share for anesthesia & respiratory devices worldwide. In addition, India and China are expected to see significant growth that will ultimately contribute to the growth of the market for anesthesia and respiratory devices in the coming years. As both countries are experiencing a high prevalence of pulmonary diseases, there is a growing demand for respiratory and anesthesia devices in emerging economies such as China, India, and Japan. According to estimates published in the International Journal of Pulmonary and Respiratory Sciences, COPD was the second largest cause of death in India in 2016. The growing pool of patients suffering from respiratory devices has resulted in a high demand for advanced medical devices consisting of anesthesia and respiratory devices that is driving the regional market.
Anesthesia & Respiratory Devices Market Players
The global anesthesia & respiratory devices companies profiled in the report include CAIRE Inc., B. Braun Medical Inc., Becton, Dickinson and Company, Medtronic plc, Drägerwerk AG, Getinge AB., GE Healthcare, Koninklijke Philips N.V., and Teleflex Incorporated.
The market size of anesthesia & respiratory devices market in 2021 was accounted to be USD 28.3 Billion.
The projected CAGR of anesthesia & respiratory devices market during the analysis period of 2022 to 2030 is 6.5%.
The prominent players of the global anesthesia & respiratory devices market are CAIRE Inc., B. Braun Medical Inc., Becton, Dickinson and Company, Medtronic plc, Drägerwerk AG, Getinge AB., GE Healthcare, Koninklijke Philips N.V., and Teleflex Incorporated.
North America held the dominating anesthesia & respiratory devices during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for anesthesia & respiratory devices during the analysis period of 2022 to 2030.
Rise incidence of respiratory disorders, rise in geriatric population, and growing number of surgical procedures drives the growth of global anesthesia & respiratory devices market.
Based on product, respiratory devices segment is expected to hold the maximum share anesthesia & respiratory devices market.